Valuation: OrganiGram Holdings Inc

Market Cap 191M 134M 118M 109M 102M 12.73B 195M 1.31B 507M 6.26B 505M 494M 21.76B P/E 2026 *
10.4x
P/E 2027 * 33.8x
Enterprise Value 191M 134M 118M 109M 102M 12.73B 195M 1.31B 507M 6.26B 505M 494M 21.76B EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.43x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 12/01/2021
Director/Board Member 68 25/02/2020
Director/Board Member - 15/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-9.65% - - 135M
-3.12%-6.63%+11.51%+82.35% 111M
-4.35%-16.98%+51.72%-29.03% 93.37M
+0.02%-9.59%+61.09%-15.37% 87.87M
-0.44%+15.74%-39.19%-53.35% 58.14M
Average -1.79%-2.54%+21.28%-3.85% 87.67M
Weighted average by Cap. -1.90%-4.38%+26.23%+5.72%

Financials

2026 *2027 *
Net sales 340M 238M 210M 194M 181M 22.58B 346M 2.33B 899M 11.1B 896M 876M 38.59B 441M 309M 273M 252M 235M 29.31B 449M 3.02B 1.17B 14.41B 1.16B 1.14B 50.09B
Net income 18.88M 13.25M 11.68M 10.77M 10.08M 1.26B 19.23M 129M 49.98M 617M 49.79M 48.7M 2.15B 6.53M 4.58M 4.04M 3.73M 3.49M 434M 6.65M 44.73M 17.29M 213M 17.22M 16.85M 742M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-